The Drug Discovery, Delivery and Patient Care (DDDPC) research group at Kingston University covers the areas of pharmacology, chemistry, drug discovery, delivery and development, pharmaceutical formulation, pharmaceutical analysis, nanotechnology and regulatory affairs.
The group's interdisciplinary research aims to improve quality of life by providing safe, effective, and innovative products and services. The research undertaken spans the diverse yet inter-connected areas of new drug and biological target discovery, pharmaceutical formulation and development of new drug delivery systems and patient care.
Many of the DDDPC group members have world-class expertise in the synthesis and biological screening of new chemical entities, identification of new biological / drug targets, development of promising new molecules into usable medicines, and monitoring how patients respond to such new medicines. The DDDPC group members are actively involved in national and international research collaboration; they work synergistically with charities, non-profit organisations, human and veterinary pharmaceutical, biotechnological, and nutraceutical industry.
Our research is focused into three main themes, namely: